Premium
The Importance of In‐Hospital Statin Therapy for Patients with Acute Coronary Syndromes
Author(s) -
ParadisoHardy Fran L.,
Gordon Wendy L.,
Jackevicius Cynthia A.,
Kertland Heather R.,
Pearson Glen J.,
Pickering Jennifer L.,
Poirier Luc,
Semchuk Bill M.,
Verret Lucie
Publication year - 2003
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1592/phco.23.4.506.32129
Subject(s) - medicine , acute coronary syndrome , statin , cardiology , intensive care medicine , myocardial infarction
Starting lipid‐lowering therapy in the hospital, especially with statins, has become an important component in the management of patients with acute coronary syndromes (ACS). It improves outcomes and increases patient motivation and long‐term adherence. In addition, discontinuation of statin therapy in patients with ACS after hospital admission is associated with an increased risk of adverse outcomes. Recent non‐ST elevation ACS guidelines recommend beginning statin therapy, along with dietary intervention, in patients whose low‐density lipoprotein cholesterol levels exceed 130 mg/dl within 24–96 hours after hospital admission. Various strategies have been developed to aid in the implementation of in‐hospital lipid‐lowering therapy. Pharmacists can play a valuable role in optimizing drug therapy for dyslipidemia and ensuring long‐term adherence.